AI assistant
Sending…
Mabpharm Limited — Share Issue/Capital Change 2019
May 30, 2019
50428_rns_2019-05-29_2cc0bf9a-1b24-4dea-84ce-182683fa5177.htm
Share Issue/Capital Change
Open in viewerOpens in your device viewer
IPO Allotment Results
![]() |
MABPHARM LIMITED (02181) |
![]() |
![]() |
![]() |
Cover |
![]() |
Summary |
![]() |
Results of applications made by applicants using White Application Forms and White Form eIPO |
![]() |
The following are the results of successful applications using White Application Forms and White Form eIPO. Applicants who have not provided their identification document numbers are not shown |
| Identification document number(s) (A1406992 to K9499156) | |
![]() |
Results of applications using yellow application forms through designated CCASS broker/custodian participants |
![]() |
The following are the results of successful applications using yellow application forms through designated CCASS broker/custodian participants. Applicants who have not provided their identification document numbers are not shown |
| Identification document number(s) (A283856A to Z2450527) | |
![]() |
There were no wholly or partially successful applicants for applications made by CCASS Investor Participants using yellow application forms. |
![]() |
Results of applications under the Hong Kong public offering by electronic application instructions given to HKSCC |
![]() |
The following are the results of successful applications made by giving electronic application instructions to HKSCC. Applicants who have not provided their identification document numbers are not shown |
| Identification document number(s) (0000523 to Z9885464) | |
![]() |
Collection / posting of share certificates and refund cheques |
More from Mabpharm Limited
Regulatory Filings
2026
May 6
Proxy Solicitation & Information Statement
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 27
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Mar 26
Earnings Release
2026
Mar 26
Report Publication Announcement
2026
Mar 12
Regulatory Filings
2026
Mar 3
